Journal News

A new way to target mosquito-borne viruses

Chloe Kirk
Nov. 16, 2022

Dengue and Zika are two mosquito-borne viruses that have evaded effective vaccine development for decades. Affecting approximately 400 million people annually, they are members of the Flaviviridae family, a group of RNA viruses that are closely related in structure.

While a handful of approved vaccines exist for certain flaviviruses in humans, including the dengue vaccine Dengvaxia, there is still significant room to improve the safety and efficacy of these vaccines, most of which show poor efficacy in animal studies and waning immunity in humans. The traditional approach uses a live-attenuated, or weakened, form of the virus that causes a disease to make the corresponding vaccine. Replication production has been a major challenge in vaccine development for flaviviruses, as live-attenuated virus vaccines have difficulty replicating evenly.

Thanh Phan and Matthew Hvasta, Ph.D. students in Brian Kuhlman’s lab at the University of North Carolina at Chapel Hill, set out to improve dengue and Zika vaccines. Instead of the traditional live-attenuated virus approach, they used small sections, or subunits, of the virus as a way for the vaccine to recognize and target the virus. In a recent paper in the Journal of Biological Chemistry, the team writes about the development of this subunit vaccine, which Phan and Hvasta describe as “putting two Tetris pieces together and having them fit as tightly as possible.”

Their research has led the two to use a soluble version of the envelope proteins, or sE, on the surface of the dengue and Zika viruses as candidates for vaccine antigens. For sE proteins to be a viable subunit vaccine, they must be easy to produce and maintain stability in the correct conformation.

Previous work in the Kuhlman lab also took this divergent vaccine approach by identifying specific dengue mutations to stabilize sE proteins for dengue serotype DENV2, which significantly raised expression yields. Phan and Hvasta used this information to test the same mutations of Zika and the remaining dengue serotypes (DENV1, 3 and 4) by searching for and mutating similar residues as those mutated for DENV2. They found increased stability as well as a fourfold to 250-fold increase in production yields.

Creating a stable, high-expression sE protein opens the door for improved dengue and Zika vaccines as well as the potential to target other viruses in the Flaviviridae family, such as yellow fever. The next steps for this project are to perform mouse studies and measure the immune response to these sE proteins.

“Our goal is to develop a safe vaccine for dengue viruses, which will directly affect countries in the (sub)tropical areas of the world where dengue is endemic,” Phan and Hvasta wrote in an email. “A safe dengue vaccine will allow these nations to reallocate funds from what would usually be used to treat dengue to hopefully being able to treat other health care necessities.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Chloe Kirk

Chloe Kirk is working toward her Ph.D. in biochemistry and molecular biology at the University of Miami. Her interests are science research, communication and outreach.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Proteomic clues to oocyte development
Journal News

Proteomic clues to oocyte development

June 7, 2023

Researchers in Nanjing, China, have identified functions of critical proteins and pathways for female germ cell maturation.

Molecular basis for interaction between an essential protein complex and its regulator
News

Molecular basis for interaction between an essential protein complex and its regulator

June 4, 2023

Mutations in COPI are associated with multiple human diseases, including cancers and microcephalies.

UTSW researchers discover how food-poisoning bacteria infect the intestines
News

UTSW researchers discover how food-poisoning bacteria infect the intestines

June 3, 2023

Findings revealing efficient assembly of virulence machine could lead to development of treatments for diseases caused by gut pathogens.

'CoA as the central core'
Interview

'CoA as the central core'

June 2, 2023

ASBMB meeting on CoA and its derivatives will take place in Wisconsin in August and will feature sessions on metabolism, intracellular cross talk, proteostasis, autophagy and technological advances in mass spectrometry.

Study uncovers a unique, efficient method of copper delivery in cells
News

Study uncovers a unique, efficient method of copper delivery in cells

May 28, 2023

Discovery will help in treating Menkes disease, other copper deficiency disorders.

As microbiome science forges ahead, will some be left behind?
Essay

As microbiome science forges ahead, will some be left behind?

May 27, 2023

The FDA’s approval of the first fecal microbiota treatment was a watershed moment — and also a wakeup call.